Tecnologías sanitarias

Empresas suizas developing health technologies

El sector de la tecnología sanitaria se caracteriza por el desarrollo de dispositivos médicos, productos de diagnóstico y plataformas de software para la asistencia sanitaria. Los plazos de aprobación reglamentaria y los modelos cambiantes de reembolso de Medicare aportan constantemente liquidez a estas acciones. En la actualidad, Novartis AG lidera el volumen de negociación, mientras que Inovio Pharmaceuticals, Inc. registra el mejor rendimiento en las últimas 24 horas. En la siguiente tabla se muestran los datos técnicos y fundamentales de gran importancia.
Símbolo
Cap. de mercado
Precio
Cbo %
Vol.
Vol. rel.
P/B
BPA dil.
TTM
Crecimiento BPA dil.
TTM YoY
Rendimiento del dividendo %
TTM
Calificación de los analistas
LLYEli Lilly and Company1,09 T CHF1.104,870 CHF−5,56%60,1343,4225,44 CHF+57,99%0,47%
Fuerte compra
LLYEli Lilly and Company
1,09 T CHF1.180 CHF+23,56%10,3146,3825,44 CHF+57,99%0,47%
Fuerte compra
JNJJohnson & Johnson543,72 B CHF227,679 CHF+3,11%120,8741,325,51 CHF−33,23%1,91%
Compra
JNJ.USDJohnson & Johnson
543,72 B CHF261,25 USD0,00%1770,3539,635,51 CHF−36,38%1,91%
Compra
ABBVAbbVie, Inc.
425,98 B CHF236,65 CHF+1,24%200,3048,724,86 CHF+360,13%2,35%
Compra
4ABAbbVie, Inc.425,98 B CHF240,889 CHF+13,10%1,35 K9,2149,604,86 CHF+360,13%2,35%
Compra
ROPRoche Holding Ltd315,59 B CHF386,324 CHF−1,65%3440,4125,2115,33 CHF+30,49%2,48%
Compra
ROPRoche Holding Ltd
315,59 B CHF390,3 CHF−0,36%1,44 M1,3025,4715,33 CHF+30,49%2,48%
Compra
RHORoche Holding Ltd315,59 B CHF405,099 CHF−0,76%150,7326,4315,33 CHF+30,49%2,69%
Compra
RORoche Holding Ltd
315,59 B CHF400,0 CHF+0,25%64,81 K2,4026,1015,33 CHF+30,49%2,69%
Compra
6MKMerck & Co., Inc.303,22 B CHF123,142 CHF+4,32%160,65150,440,82 CHF−86,41%2,26%
Compra
MRK.USDMerck & Co., Inc.
303,22 B CHF151,22 USD0,00%1,24 K0,89154,430,82 CHF−87,05%2,26%
Compra
NOTNovartis AG245,77 B CHF132,760 CHF−1,75%1270,2432,004,15 CHF−33,04%2,76%
Neutral
NOVNNovartis AG
245,77 B CHF133,08 CHF−0,78%4,01 M1,0032,074,15 CHF−33,04%2,76%
Neutral
NOVNEENovartis AG TEMP
245,77 B CHF132,56 CHF−1,88%130 K0,4531,954,15 CHF−33,04%2,76%
Sin valoración
ZEGAstraZeneca PLC239,39 B CHF155,416 CHF+1,57%2119,9126,625,84 CHF+18,22%1,70%
Compra
TN8Thermo Fisher Scientific Inc.213,87 B CHF546,250 CHF−2,06%20,6534,4815,84 CHF+14,93%0,26%
Compra
AMGAmgen Inc.211,44 B CHF388,337 CHF+1,70%90,7626,9414,41 CHF+39,89%2,08%
Neutral
GISGilead Sciences, Inc.176,9 B CHF134,099 CHF−5,57%200,15—−2,63 CHF−151,18%1,86%
Compra
ABLAbbott Laboratories163,38 B CHF94,775 CHF+6,44%63130,0541,862,26 CHF−64,34%2,18%
Compra
NVONovo Nordisk A/S Sponsored ADR Class B
DR
154,8 B CHF33,873 CHF+4,89%300,0310,213,32 CHF+21,39%2,92%
Neutral
NOVNovo Nordisk A/S Class B154,8 B CHF33,068 CHF+0,66%2480,1410,273,22 CHF+10,70%4,10%
Neutral
PFEPfizer Inc.143,45 B CHF23,577 CHF−5,69%4,31 K10,2840,340,58 CHF−57,23%5,59%
Neutral
IUI1Intuitive Surgical, Inc.136,6 B CHF375,728 CHF−4,11%251,5954,386,91 CHF+14,81%0,00%
Compra
DAPDanaher Corporation135,1 B CHF187,464 CHF−1,94%1,65 K44,5936,725,11 CHF+31,91%0,65%
Compra
VX1Vertex Pharmaceuticals Incorporated113,78 B CHF439,008 CHF−2,56%100,3033,7812,99 CHF+14,99%0,00%
Compra
2M6Medtronic Plc109,74 B CHF85,457 CHF−0,24%40,1526,043,28 CHF+11,14%2,72%
Compra
BRMBristol-Myers Squibb Company107,25 B CHF51,175 CHF+1,34%100,0313,573,77 CHF+59,93%3,93%
Compra
SYKStryker Corporation105,69 B CHF257,002 CHF+2,09%70,1332,757,85 CHF+29,36%1,04%
Compra
SANSanofi SA
92,58 B CHF67,98 CHF0,00%4500,1322,123,07 CHF−36,38%4,90%
Compra
SNWSanofi SA92,58 B CHF77,442 CHF+6,14%4952,8225,203,07 CHF−36,38%4,90%
Compra
MRNAModerna, Inc.
84,32 B CHF161,56 CHF−20,41%8——−6,45 CHF−8,21%0,00%
Neutral
0QFModerna, Inc.84,32 B CHF214,368 CHF+8,91%2,19 K10,49—−6,45 CHF−8,21%0,00%
Neutral
MRNA.USDModerna, Inc.
84,32 B CHF226,80 USD0,00%1,93 K1,55—−6,45 CHF−6,20%0,00%
Neutral
GS71GSK plc83,39 B CHF20,522 CHF+1,52%30,0417,341,18 CHF−17,14%3,60%
Neutral
EL1EssilorLuxottica SA
80,36 B CHF179,30 CHF0,00%1,73 K1,5736,294,94 CHF+2,56%2,12%
Compra
ESLEssilorLuxottica SA80,36 B CHF175,776 CHF+9,63%1001,1335,584,94 CHF+2,56%2,12%
Compra
MRKMerck KGaA60,03 B CHF138,411 CHF+6,22%2001,6827,505,03 CHF−18,23%1,46%
Compra
BSXBoston Scientific Corporation54,29 B CHF37,640 CHF−0,39%5002,7419,061,97 CHF+32,59%0,00%
Compra
CSJCSL Limited54,2 B CHF113,768 CHF−1,02%3861,17—−4,25 CHF−186,00%2,05%
Compra
UNCUCB S.A.49,28 B CHF254,278 CHF+5,56%301,0324,3610,44 CHF+62,96%0,36%
Compra
BAYNBayer AG
48,9 B CHF43,46 CHF0,00%6000,69—−1,63 CHF+49,77%0,20%
Compra
BAYNBayer AG48,9 B CHF50,052 CHF−2,26%4800,51—−1,63 CHF+49,77%0,20%
Compra
SHLSiemens Healthineers AG45,93 B CHF40,107 CHF−2,47%40,0622,011,82 CHF+1,10%2,23%
Compra
SHLSiemens Healthineers AG
45,93 B CHF41,12 CHF+11,14%250,0222,561,82 CHF+1,10%2,23%
Compra
GALDGalderma Group AG
45,37 B CHF191,75 CHF−1,74%580,42 K1,0366,032,90 CHF+110,71%0,18%
Compra
GALDGalderma Group AG45,37 B CHF189,334 CHF−3,60%2130,8865,202,90 CHF+110,71%0,18%
Compra
LO3Lonza Group AG45,09 B CHF658,428 CHF−2,15%340,12—−1,55 CHF−115,18%0,76%
Compra
LONNLonza Group AG
45,09 B CHF663,4 CHF−1,34%212,06 K1,42—−1,55 CHF−115,18%0,76%
Compra
IX1IDEXX Laboratories, Inc.44,99 B CHF561,726 CHF+28,10%1004,3745,2912,40 CHF+23,43%0,00%
Compra
SDZSandoz Group Ltd
36,14 B CHF83,78 CHF+0,19%893 K0,6171,161,18 CHF+166,48%0,97%
Neutral
D8YSandoz Group Ltd36,14 B CHF83,263 CHF+0,29%1,07 K1,7070,721,18 CHF+166,48%0,97%
Neutral
RVMDRevolution Medicines, Inc.34,99 B CHF150,462 CHF−4,57%590,85—−7,13 CHF−99,36%0,00%
Fuerte compra
ALCAlcon AG
31,62 B CHF61,30 CHF−2,36%1,23 M1,2759,121,04 CHF−44,92%0,44%
Compra
2U3Alcon AG31,62 B CHF60,879 CHF−3,84%1,21 K1,5858,721,04 CHF−44,92%0,44%
Compra
ZOEZoetis, Inc. Class A30,13 B CHF65,569 CHF+0,36%100,2113,344,91 CHF+6,56%2,38%
Neutral
DC4DexCom, Inc.26,97 B CHF64,471 CHF−10,31%9367,8130,232,13 CHF+49,03%0,00%
Fuerte compra
IM8NInsmed Incorporated19,73 B CHF91,668 CHF−4,48%48——−2,35 CHF+52,19%0,00%
Fuerte compra
22UABioNTech SE Sponsored ADR
DR
18,62 B CHF70,648 CHF−5,05%330,78—−6,34 CHF−399,64%0,00%
Compra
VTRSViatris, Inc.18,04 B CHF15,755 CHF+4,80%741,31—−0,29 CHF+87,49%2,50%
Compra
DULAlnylam Pharmaceuticals, Inc17,64 B CHF138,579 CHF−27,27%1001,998,3716,55 CHF+8.543,33%0,00%
Compra
ZBHZimmer Biomet Holdings, Inc.
17,17 B CHF76,0 CHF+1,33%340,4023,033,30 CHF+2,53%0,87%
Neutral
STMNStraumann Holding AG
17,12 B CHF104,50 CHF−1,28%363,31 K0,7945,172,31 CHF−5,94%0,93%
Compra
QS51Straumann Holding AG17,12 B CHF106,125 CHF−0,81%1030,6945,872,31 CHF−5,94%0,93%
Compra
PHBNSonova Holding AG16,68 B CHF287,176 CHF−1,86%1280,3439,777,22 CHF−20,12%1,62%
Neutral
SOONSonova Holding AG
16,68 B CHF288,0 CHF−1,44%197,29 K1,4239,887,22 CHF−20,12%1,62%
Neutral
EX9Exelixis, Inc.14,51 B CHF53,452 CHF+0,45%4001,2119,142,79 CHF+47,64%0,00%
Compra
CBHDColoplast A/S Class B14,4 B CHF59,193 CHF+1,18%2 K11,2334,341,72 CHF−14,44%4,40%
Neutral
WDH1Demant A/S9,42 B CHF45,623 CHF+35,57%7 K40,7048,030,95 CHF−29,67%0,00%
Compra
QGENQIAGEN NV8,58 B CHF41,772 CHF+40,91%100,1026,251,59 CHF+11,53%0,69%
Neutral
YDO1Madrigal Pharmaceuticals, Inc.7,6 B CHF358,641 CHF−0,42%120,38—−5,00 CHF+51,78%0,00%
Fuerte compra
HDP1Arrowhead Pharmaceuticals, Inc.7,12 B CHF50,112 CHF−7,82%2 K17,39—−1,81 CHF−80,90%0,00%
Fuerte compra
BANBBachem Holding AG Class B
6,12 B CHF79,70 CHF−0,06%58,18 K0,7840,101,99 CHF+11,05%1,10%
Compra
BANBBachem Holding AG Class B6,12 B CHF78,273 CHF−3,74%120,1539,381,99 CHF+11,05%1,10%
Compra
OWXYpsomed Holding AG5,28 B CHF387,308 CHF−4,22%10,0423,7616,30 CHF+154,29%1,10%
Compra
YPSNYpsomed Holding AG
5,28 B CHF394,4 CHF−0,05%8,88 K0,7924,2016,30 CHF+154,29%1,10%
Compra
1CGCRISPR Therapeutics AG4,11 B CHF40,056 CHF−2,75%6001,15—−3,97 CHF+10,71%0,00%
Compra
SFZNSiegfried Holding AG
3,38 B CHF72,00 CHF−1,37%104,69 K0,9418,413,91 CHF+11,09%0,53%
Compra
SFZNSiegfried Holding AG3,38 B CHF71,467 CHF−3,66%320,1618,283,91 CHF+11,09%0,53%
Compra
IOVAIovance Biotherapeutics Inc3,22 B CHF7,100 CHF−40,91%300——−0,58 CHF+40,09%0,00%
Compra
FIEFielmann Group AG3,19 B CHF36,668 CHF+1,13%1 K6,4915,752,33 CHF+23,36%3,38%
Compra
TENTecan Group AG3,14 B CHF253,933 CHF−4,60%561,10—−9,16 CHF−284,91%1,23%
Compra
TECNTecan Group AG
3,14 B CHF257,6 CHF−1,68%75,47 K0,91—−9,16 CHF−284,91%1,23%
Compra
AFXCarl Zeiss Meditec AG2,94 B CHF32,719 CHF+1,21%1000,2132,701,00 CHF−41,01%1,54%
Venta
6MDMedacta Group SA2,48 B CHF106,788 CHF−10,36%1701,8129,853,58 CHF−20,27%0,89%
Compra
MOVEMedacta Group SA
2,48 B CHF106,4 CHF−13,64%142,07 K4,9229,743,58 CHF−20,27%0,89%
Compra
EZP1COMET Holding AG2,48 B CHF304,344 CHF+2,26%40,08132,652,29 CHF−54,20%0,16%
Fuerte compra
COTNCOMET Holding AG
2,48 B CHF298,0 CHF−0,13%57,39 K1,51129,882,29 CHF−54,20%0,16%
Fuerte compra
RXRXRecursion Pharmaceuticals, Inc. Class A1,98 B CHF3,117 CHF−4,45%4 K5,28—−0,75 CHF+48,25%0,00%
Compra
NDH1Metall Zug AG Class B1,8 B CHF820,202 CHF−0,27%20,21—−12,44 CHF+56,17%0,00%
Neutral
METNMetall Zug AG Class B
1,8 B CHF835 CHF0,00%2282,26—−12,44 CHF+56,17%0,00%
Neutral
7VGSKAN Group AG1,61 B CHF73,514 CHF+1,51%410,4055,121,33 CHF+85,35%0,31%
Fuerte compra
SKANSKAN Group AG
1,61 B CHF69,7 CHF−0,99%33,43 K0,9452,261,33 CHF+85,35%0,31%
Fuerte compra
MEDMedartis Holding AG
1,51 B CHF109,6 CHF+2,05%14,27 K0,7891,441,20 CHF—0,00%
Fuerte compra
NVV1Novavax, Inc.1,44 B CHF8,008 CHF−3,65%5001,61—−1,23 CHF−168,74%0,00%
Compra
PPGNPolyPeptide Group AG
1,36 B CHF40,05 CHF−1,11%21,45 K0,9799,080,40 CHF—0,00%
Neutral
8H0PolyPeptide Group AG1,36 B CHF43,866 CHF−0,37%4000,36108,530,40 CHF—0,00%
Neutral
PPPGNEPolyPeptide Group AG TEMP
1,36 B CHF44,00 CHF+0,34%1,97 K0,19108,860,40 CHF—0,00%
Sin valoración
IDIAIdorsia Ltd.
1,19 B CHF4,058 CHF−3,38%997,2 K1,24—−1,11 CHF−66,32%0,00%
Neutral
19TIdorsia Ltd.1,19 B CHF4,023 CHF−8,69%1000,08—−1,11 CHF−66,32%0,00%
Neutral